118 related articles for article (PubMed ID: 32141544)
1. Downregulated LINC00628 aggravates the progression of colorectal cancer via inhibiting p57 level.
Zhang MC; Zhang L; Zhang MQ; Yang GX; Wang FZ; Ding P
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1763-1770. PubMed ID: 32141544
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.
Ma Z; Gu S; Song M; Yan C; Hui B; Ji H; Wang J; Zhang J; Wang K; Zhao Q
Mol Biosyst; 2017 Oct; 13(11):2350-2361. PubMed ID: 28933484
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57
Qiao E; Chen D; Li Q; Feng W; Yu X; Zhang X; Xia L; Jin J; Yang H
J Cell Biochem; 2019 Mar; 120(3):3978-3988. PubMed ID: 30378143
[TBL] [Abstract][Full Text] [Related]
5. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer.
Gong A; Huang Z; Ge H; Cai Y; Yang C
J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of ZEB2-AS1 inhibits cell invasion and induces apoptosis in colorectal cancer.
Wu X; Zhu H; Xie Y; Gu X; Zhang L; Huang L
J BUON; 2020; 25(1):194-201. PubMed ID: 32277632
[TBL] [Abstract][Full Text] [Related]
7. Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
Xie Y; Wang F; Yu J; Zhang J; Liu Y; Li M; Qi J
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617573
[TBL] [Abstract][Full Text] [Related]
8. Upregulated lncRNA CACNA1G-AS1 aggravates the progression of colorectal cancer by downregulating p53.
Wei LJ; Bai DM; Wang ZY; Liu BC
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):130-136. PubMed ID: 31957825
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
[TBL] [Abstract][Full Text] [Related]
10. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
[TBL] [Abstract][Full Text] [Related]
11. [MicroRNA-221 controls CDKN1C/P57 expression in human colorectal carcinoma].
Sun K; Zeng JJ; Wang W; Wu CT; Lei ST; Li GX
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Apr; 14(4):279-83. PubMed ID: 21538272
[TBL] [Abstract][Full Text] [Related]
12. LncRNA BDNF-AS suppresses colorectal cancer cell proliferation and migration by epigenetically repressing GSK-3β expression.
Zhi H; Lian J
Cell Biochem Funct; 2019 Jul; 37(5):340-347. PubMed ID: 31062382
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FOXC2-AS1 stimulates proliferation of melanoma via silencing p15 by recruiting EZH2.
Xu DF; Tao XH; Yu Y; Teng Y; Huang YM; Ma JW; Fan YB
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8940-8946. PubMed ID: 32964984
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.
Zhang G; Xu Y; Wang S; Gong Z; Zou C; Zhang H; Ma G; Zhang W; Jiang P
J Cell Physiol; 2019 Apr; 234(4):5163-5174. PubMed ID: 30256413
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression.
Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G
Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796
[TBL] [Abstract][Full Text] [Related]
16. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
17. Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer.
Ishikawa S; Hayashi H; Kinoshita K; Abe M; Kuroki H; Tokunaga R; Tomiyasu S; Tanaka H; Sugita H; Arita T; Yagi Y; Watanabe M; Hirota M; Baba H
Int J Cancer; 2014 Dec; 135(11):2528-36. PubMed ID: 24346863
[TBL] [Abstract][Full Text] [Related]
18. LINC01116 facilitates colorectal cancer cell proliferation and angiogenesis through targeting EZH2-regulated TPM1.
Liang W; Wu J; Qiu X
J Transl Med; 2021 Jan; 19(1):45. PubMed ID: 33499872
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA RUNX1-IT1 plays a tumour-suppressive role in colorectal cancer by inhibiting cell proliferation and migration.
Shi J; Zhong X; Song Y; Wu Z; Gao P; Zhao J; Sun J; Wang J; Liu J; Wang Z
Cell Biochem Funct; 2019 Jan; 37(1):11-20. PubMed ID: 30499136
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2.
Guo M; Zhang X
World J Surg Oncol; 2022 Mar; 20(1):95. PubMed ID: 35346226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]